Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Krox20 is crucial for hair growth and maintaining skin stem cells.

LLPS is crucial for RALF signaling, aiding plant growth and stress resilience.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

RALF22 is essential for root hair growth in response to fungal emissions in Arabidopsis.

Gene variation affects prostate issues and hair loss.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Shorter GGN repeats in the androgen receptor gene are linked to androgenetic alopecia.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

The new method improves accuracy in segmenting scalp tissue layers.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A feedback loop between LRH and RSL4 controls root hair growth in Arabidopsis.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Mutations in specific llama genes may affect fiber quality for textiles.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Genetic marker rs12558842 strongly linked to male hair loss.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

RUM-loaded SLN shows promise for treating acne and hair loss topically.